Gallbladder and biliary tract histology

WikiDoc Resources for Gallbladder and biliary tract histology
Articles
Most recent articles on Gallbladder and biliary tract histology Most cited articles on Gallbladder and biliary tract histology Review articles on Gallbladder and biliary tract histology Articles on Gallbladder and biliary tract histology in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Gallbladder and biliary tract histology Images of Gallbladder and biliary tract histology Photos of Gallbladder and biliary tract histology Podcasts & MP3s on Gallbladder and biliary tract histology Videos on Gallbladder and biliary tract histology
Evidence Based Medicine
Cochrane Collaboration on Gallbladder and biliary tract histology Bandolier on Gallbladder and biliary tract histology TRIP on Gallbladder and biliary tract histology
Clinical Trials
Ongoing Trials on Gallbladder and biliary tract histology at Clinical Trials.gov Trial results on Gallbladder and biliary tract histology Clinical Trials on Gallbladder and biliary tract histology at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Gallbladder and biliary tract histology NICE Guidance on Gallbladder and biliary tract histology NHS PRODIGY Guidance FDA on Gallbladder and biliary tract histology CDC on Gallbladder and biliary tract histology
Books
Books on Gallbladder and biliary tract histology
News
Gallbladder and biliary tract histology in the news Be alerted to news on Gallbladder and biliary tract histology News trends on Gallbladder and biliary tract histology
Commentary
Blogs on Gallbladder and biliary tract histology
Definitions
Definitions of Gallbladder and biliary tract histology
Patient Resources / Community
Patient resources on Gallbladder and biliary tract histology Discussion groups on Gallbladder and biliary tract histology Patient Handouts on Gallbladder and biliary tract histology Directions to Hospitals Treating Gallbladder and biliary tract histology Risk calculators and risk factors for Gallbladder and biliary tract histology
Healthcare Provider Resources
Symptoms of Gallbladder and biliary tract histology Causes & Risk Factors for Gallbladder and biliary tract histology Diagnostic studies for Gallbladder and biliary tract histology Treatment of Gallbladder and biliary tract histology
Continuing Medical Education (CME)
CME Programs on Gallbladder and biliary tract histology
International
Gallbladder and biliary tract histology en Espanol Gallbladder and biliary tract histology en Francais
Business
Gallbladder and biliary tract histology in the Marketplace Patents on Gallbladder and biliary tract histology
Experimental / Informatics
List of terms related to Gallbladder and biliary tract histology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Your Name

Synonyms and keywords: Synonym 1; Synonym 2; Synonym 3

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Historical Perspective

• [Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
• In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
• In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].

Classification

• [Disease name] may be classified according to [classification method] into [number] subtypes/groups:

• [group1]
• [group2]
• [group3]

• Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

• The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
• The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
• On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
• On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Causes

• [Disease name] may be caused by either [cause1], [cause2], or [cause3].
• [Disease name] is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
• There are no established causes for [disease name].

Differentiating [disease name] from other Diseases

• [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:

• [Differential dx1]
• [Differential dx2]
• [Differential dx3]

Epidemiology and Demographics

• The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
• In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

• Patients of all age groups may develop [disease name].

• [Disease name] is more commonly observed among patients aged [age range] years old.
• [Disease name] is more commonly observed among [elderly patients/young patients/children].

Gender

• [Disease name] affects men and women equally.

• [Gender 1] are more commonly affected with [disease name] than [gender 2].
• The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

• There is no racial predilection for [disease name].

• [Disease name] usually affects individuals of the [race 1] race.
• [Race 2] individuals are less likely to develop [disease name].

Risk Factors

• Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

• The majority of patients with [disease name] remain asymptomatic for [duration/years].
• Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
• If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
• Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
• Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].

Diagnosis

Diagnostic Criteria

• The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:

• [criterion 1]
• [criterion 2]
• [criterion 3]
• [criterion 4]

Symptoms

• [Disease name] is usually asymptomatic.
• Symptoms of [disease name] may include the following:

• [symptom 1]
• [symptom 2]
• [symptom 3]
• [symptom 4]
• [symptom 5]
• [symptom 6]

Physical Examination

• Patients with [disease name] usually appear [general appearance].
• Physical examination may be remarkable for:

• [finding 1]
• [finding 2]
• [finding 3]
• [finding 4]
• [finding 5]
• [finding 6]

Laboratory Findings

• There are no specific laboratory findings associated with [disease name].

• A [positive/negative] [test name] is diagnostic of [disease name].
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
• Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

• There are no [imaging study] findings associated with [disease name].

• [Imaging study 1] is the imaging modality of choice for [disease name].
• On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
• [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

• [Disease name] may also be diagnosed using [diagnostic study name].
• Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

• There is no treatment for [disease name]; the mainstay of therapy is supportive care.

• The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action 1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

• Surgery is the mainstay of therapy for [disease name].
• [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
• [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention

• There are no primary preventive measures available for [disease name].

• Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

• Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].